Table 5.
Path analysis results – unstandardised regression coefficients and confidence intervals.
| Outcome | Predictor | B [95%CI] | p |
|---|---|---|---|
| GAD-7 | |||
| Group | 1.90 [0.93, 2.87] | < .001 | |
| Pre-Treatment GAD | 0.46 [0.34, 0.59] | < .001 | |
| Age | −0.01 [-0.06, 0.03] | .573 | |
| Group * Pre-Treatment | 0.12 [-0.06, 0.31] | .184 | |
| Group * Age | −0.02 [-0.08, 0.04] | .478 | |
| PHQ-9 | |||
| Group | 1.58 [0.61, 2.55] | .001 | |
| Pre-Treatment PHQ | 0.56 [0.45, 0.67] | < .001 | |
| Age | −0.02 [-0.07, 0.02] | .268 | |
| Group * Pre-Treatment | 0.21 [0.05, 0.36] | .009 | |
| Group * Age | −0.02 [-0.08, 0.04] | .416 | |
Note. GAD-7 = Generalised Anxiety Disorder Questionnaire (Spitzer et al., 2006); PHQ-9 = Patient Health Questionnaire (PHQ-9; Kroenke et al., 2001). A model with gender as a moderator (excluding 2 non-binary individuals and 1 who did not wish to report their gender) showed a similar pattern of results and no direct or moderating effects of gender.